David Dyment Receives Can-GARD Grant


Ottawa, Ontario — Tuesday July 7, 2020

Dr. David Dyment received the Can-GARD: Advanced Therapies for Rare Diseases 2020 Spring Accelerator Grant, receiving $150,000.00 over 2 years for his study “Modulating sphingolipid metabolism to improve outcome in a mouse model of spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME)”

Can-GARD aims to fund proposals that would eliminate barriers in the diagnostic or treatment journey for rare disease patients.

Areas of Research